or Try an Advanced Search...

    Solid Tumors Stocks List

    Symbol Grade Name % Change
    ADAP D Adaptimmune Therapeutics plc -4.35
    CRDF D Cardiff Oncology, Inc. -4.34
    ATRA F Atara Biotherapeutics, Inc. -4.32
    NXTC D NextCure, Inc. -4.24
    STTK B Shattuck Labs, Inc. -3.85
    ANIX F Anixa Biosciences, Inc. -3.64
    PRLD D Prelude Therapeutics Incorporated -3.39
    VINC F Vincera Pharma, Inc. -3.18
    CARM F Carisma Therapeutics, Inc. -2.82
    CRBU F Caribou Biosciences, Inc. -2.61
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
    Related Stock Lists: Medicine Biopharmaceutical Cancer Clinical Medicine Cancer Treatment Leukemia Lymphoma Ovarian Cancer Biotechnology Advanced Solid Tumors Cancer Immunotherapy Cell Therapy Chimeric Antigen Receptor T Cell Clinical Development Drugs Immune System Immunotherapy Multiple Myeloma Non Small Cell Lung Cancer Oncolytics Biotech

    Related ETFs - A few ETFs which own one or more of the above listed Solid Tumors stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 1.99
    WDNA D WisdomTree BioRevolution Fund 0.96
    GNOM D Global X Genomics & Biotechnology ETF 0.54
    BBC C Virtus LifeSci Biotech Clinical Trials ETF 0.5
    LABD D Direxion Daily S&P Biotech Bear 3X Shares 0.41
    View all Solid Tumors ETFs...
    Compare ETFs
    Compare CNCR to LABD Compare GNOM to BBC Compare WDNA to GNOM

        Solid Tumors Stocks Recent News

        Date Stock Title
        May 7 STTK What Makes Shattuck Labs (STTK) a New Buy Stock
        May 7 STTK Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?
        May 7 ANIX Sidoti Events, LLC's Virtual May Micro-Cap Conference
        May 7 PRLD Prelude Therapeutics GAAP EPS of -$0.42
        May 7 PRLD Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
        May 6 ANIX Anixa Biosciences CEO Featured on "Target: Cancer Podcast" by Oncologist Dr. Sanjay Juneja
        May 6 CARM Carisma Therapeutics to Participate in The Citizens JMP Life Sciences Conference
        May 4 CRDF Cardiff Oncology First Quarter 2024 Earnings: Beats Expectations
        May 4 STTK Shattuck Labs First Quarter 2024 Earnings: Beats Expectations
        May 4 STTK Shattuck Labs Inc (STTK) Reports First Quarter 2024 Financial Results
        May 3 CRDF Cardiff Oncology, Inc. (CRDF) Q1 2023 Earnings Call Transcript
        May 2 NXTC NextCure GAAP EPS of -$0.61 misses by $0.15
        May 2 CRDF Cardiff Oncology GAAP EPS of -$0.22 beats by $0.03, revenue of $0.2M beats by $0.14M
        May 2 CRDF Cardiff Oncology Reports First Quarter 2024 Results and Provides Business Update
        May 2 NXTC NextCure Provides Business Update and Reports First Quarter 2024 Financial Results
        May 2 CARM Carisma Therapeutics Inc. (CARM) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
        May 2 STTK Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Tops Revenue Estimates
        May 2 STTK Shattuck Labs GAAP EPS of -$0.37, revenue of $1.11M
        May 2 CARM Carisma Therapeutics names Eugene Kennedy as chief medical officer
        May 2 CARM Carisma Therapeutics Appoints Dr. Eugene P. Kennedy as Chief Medical Officer
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Long-Term Care Facilities Medical Devices Other Shell Companies
        Related Stock Lists: Medicine Biopharmaceutical Cancer Clinical Medicine Cancer Treatment Leukemia Lymphoma Ovarian Cancer Biotechnology Advanced Solid Tumors Cancer Immunotherapy Cell Therapy Chimeric Antigen Receptor T Cell Clinical Development Drugs Immune System Immunotherapy Multiple Myeloma Non Small Cell Lung Cancer Oncolytics Biotech
        Solid Tumors

        Solid tumors are masses of abnormal cells that form when cells in the body divide and grow uncontrollably. They are usually found in the organs, but can also form in the tissues of the body. Solid tumors can be benign (non-cancerous) or malignant (cancerous).

        Browse All Tags